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Objective: To study the expression of tumor necrosis factor receptor-associated protein 1
(TRAP1) in gastric cancer tissue and its correlation with malignant biology.
Methods: Gastric cancer tissue and adjacent normal tissue were collected, and mRNA
content and protein content of TRAP1 were detected; gastric cancer cell lines SGC7901,
BGC823, AGS and MGC803 were cultured, and mRNA contents and protein contents of
TRAP1, CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF were detected.
Results: mRNA and protein expression levels of TRAP1 in gastric cancer tissue were
signiﬁcantly higher than those in adjacent normal tissue, and mRNA and protein
expression levels of TRAP1 in gastric cancer tissue with muscularis and serosa inﬁltra-
tion, lymph node metastasis, distant organ metastasis and TNM Ⅲ/Ⅳ stage were
signiﬁcantly higher than those in gastric cancer tissue with mucosa and submucosa
inﬁltration, non-lymph node metastasis, non-distant organ metastasis and TNM Ⅰ/Ⅱ stage.
mRNA and protein expression levels of TRAP1, CyclinB1, CyclinD1, CyclinE, MMP-2
and VEGF in MGC803 were the highest, and mRNA and protein expression levels of
TRAP1, CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF in SGC7901 were the lowest.
mRNA and protein expression levels of TRAP1 in gastric cancer cell lines were posi-
tively correlated with mRNA and protein expression of CyclinB1, CyclinD1, CyclinE,
MMP-2 and VEGF.
Conclusions: The expression of TRAP1 signiﬁcantly increases in gastric cancer tissue;
TRAP1 may regulate the malignant biology of cells by increasing the expression of
CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF, thereby resulting in the occurrence
and development of gastric cancer.1. Introduction
Gastric cancer is the malignant tumor of digestive tract sys-
tem with the highest incidence in our country. Surgical resection
is the main method of treating gastric cancer, and auxiliary
postoperative chemotherapy and targeted therapy can effectively
clear the lesions of gastric cancer and prolong the survival time
of patients [1]. Nonetheless, the condition of patients with gastric
cancer will inevitably develop into local recurrence and distant
metastasis, and 5-year survival rate is not satisfactory [2]. At
present, there are still no speciﬁc targeted therapy drugs for
gastric cancer, which is related to that fact that pathogenesis-related genes of gastric caner have not been fully elucidated.
Tumor necrosis factor receptor-associated protein 1 (TRAP1),
also known as HSP75, is a molecular chaperone closely related
to the regulation of cell proliferation and apoptosis. Studies have
reported that TRAP1 is related to the occurrence of malignant
tumors of digestive tract such as colon cancer, esophageal cancer
[3,4]. Thus, a hypothesis was put forward that TRAP1 might
regulate malignant biological behaviors of gastric cancer and
participate in the development of gastric cancer. In order to
verify the hypothesis, the expression of TRAP1 in gastric
cancer tissue and its correlation with malignant biology were
analyzed.2. Materials and methods
2.1. Experimental materials
Gastric cancer tissue and adjacent normal tissue were from 40
cases of patients receiving radical resection for gastric cancer iner the CC BY-NC-ND license (http://
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lines SGC7901, BGC823, AGS and MGC803 were purchased
from Cell Bank of ATCC, cell culture media were from Gibco
Company and consumable materials were from Corning Com-
pany; PCR kits of TRAF1, CyclinB1, CyclinD1, CyclinE,
MMP-2 and VEGF were from TAKARA Company and
monoclonal antibodies were from Santa Cruz Company.
2.2. Experimental instruments
Cell culture incubator and centrifuge were from Thermo
Company, and ﬂuorescent quantitative PCR apparatus and
chemiluminescence apparatus were from Bio-Rad Company.
2.3. Experimental methods
2.3.1. Tissue sample collecting
At the end of operation, gastric cancer tissue and adjacent
normal tissue were collected, immunohistochemistry staining
was used to conﬁrm the nature of tissue, then normal saline was
used to wash away residual blood and clot from the tissue, and
after absorbing the moisture, tissue was put in freezing tube and
then preserved in ultralow temperature freezer in the long term.
2.3.2. Cell culturing and collecting
Media containing 10% fetal bovine serum were used for cell
culture, and cell growth was observed under microscope. When
the density of cells in culture bottles grew to about 80%, trypsin
digestion and passage were carried out with 0.125% concen-
tration of trypsin, and after passage, cells were seeded in Petri
dishes with diameter of 3.5 mm; when the density of cells in
Petri dishes grew to 90%, media were discarded and Petri dishes
were collected and preserved in ultralow temperature freezer.
2.3.3. Detection of mRNA expression
Tissue and cell samples were taken, and RNA extraction kits
and reverse transcription kits were used for experiment. After
cDNA samples were obtained, primers of target genes to be
tested were designed and PCR kits were used to amplify TRAF1,
CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF. b-actin was
used as standardized internal reference among groups and
mRNA expression levels of above target genes were calculated.
PCR ampliﬁcation conditions were as follows: 95 C for 15 s,
speciﬁc annealing temperature for 20 s, 72 C for 25 s, and
repeating 40 cycles.Table 1
mRNA and protein expression levels of TRAP1 in gastric cancer tissue.
Clinical pathological features Groups Case
Tissue origin Adjacent normal tissue 40
Gastric cancer tissue 40
Inﬁltration depth Mucosa and submucosa 22
Muscularis and serosa 18
Lymph node metastasis Without 25
With 15
Distant organ metastasis Without 28
With 12
TNM stage Ⅰ/Ⅱ stage 24
Ⅲ/Ⅳ stage 16
a Compared with adjacent normal tissue, P < 0.05. b Compared with gas
c Compared with gastric cancer tissue without lymph node metastasis, P
metastasis, P < 0.05. e Compared with gastric cancer tissue with TNM Ⅰ/Ⅱ2.3.4. Detection of protein expression
Tissue and cell samples were taken and added to protein
lysate, and obtained protein samples were treated according
to process and then added to polyacrylamide gel for elec-
trophoresis, transmembrane, antigen site closure, antibody
incubation and ECL development in turn to get corresponding
bands of proteins, and grey values of the bands were scanned.
b-actin was used as standardized internal reference among
groups and protein expression levels of above target genes
were calculated.
2.3.5. Statistical methods
SPSS21.0 software was used for statistical processing.
After experimental data was input, comparison between two
groups was by t test, comparison among groups was by
variance analysis and correlation analysis was by Pearson
test. P < 0.05 was the standard of statistical signiﬁcance in
difference.
3. Results
3.1. TRAP1 expression in gastric cancer tissue
mRNA and protein expression levels of TRAP1 in gastric
cancer tissue were signiﬁcantly higher than those in adjacent
normal tissue; analysis of TRAP1 expression in gastric cancer
tissue with different clinical pathological features was as fol-
lows: mRNA and protein expression levels of TRAP1 in gastric
cancer tissue with muscularis and serosa inﬁltration, lymph
node metastasis, distant organ metastasis and TNM Ⅲ/Ⅳ stage
were signiﬁcantly higher than those in gastric cancer tissue with
mucosa and submucosa inﬁltration, non-lymph node metas-
tasis, non-distant organ metastasis and TNM Ⅰ/Ⅱ stage
(Table 1).
3.2. TRAP1 expression in gastric cancer cell lines
mRNA expression levels of TRAP1 in gastric cancer cell
lines SGC7901, BGC823, AGS and MGC803 were 62.35 ±
7.84, 163.45 ± 19.33, 100 ± 12.85 and 253.35 ± 28.69 respec-
tively; protein expression levels were 57.68 ± 6.34, 168.68 ±
22.12, 100 ± 12.59 and 278.38 ± 31.45 respectively. Variance
analysis showed: mRNA expression levels and protein expres-
sion levels of TRAP1 in gastric cancer cell lines SGC7901,(n) mRNA content of TRAF1 Protein content of TRAF1
100.00 ± 14.52 100.00 ± 12.96
237.28 ± 28.75a 262.39 ± 31.46a
165.63 ± 18.95 178.65 ± 21.47
289.52 ± 31.34b 314.67 ± 32.68b
149.59 ± 16.34 159.65 ± 16.84
313.58 ± 36.95c 338.91 ± 37.52c
157.49 ± 17.14 166.79 ± 18.44
304.59 ± 34.27d 329.42 ± 35.67d
170.34 ± 21.42 189.43 ± 21.34
276.75 ± 29.58e 301.38 ± 36.41e
tric cancer tissue with mucosa and submucosa inﬁltration, P < 0.05.
< 0.05. d Compared with gastric cancer tissue without distant organ
stage, P < 0.05.
Table 2
mRNA contents of malignant biological behavior-related molecules in gastric cancer cell lines.
Cell lines Proliferation-related molecules Invasion molecules
CyclinB1 CyclinD1 CyclinE MMP-2 VEGF
SGC7901 59.97 ± 7.85 66.72 ± 7.54 47.23 ± 5.02 51.34 ± 7.39 62.21 ± 7.23
BGC823 162.32 ± 23.12 146.79 ± 15.96 152.46 ± 16.75 144.58 ± 17.38 149.04 ± 16.12
AGS 100.00 ± 12.46 100.00 ± 13.04 100.00 ± 14.14 100.00 ± 12.71 100.00 ± 11.59
MGC803 294.58 ± 32.42 328.39 ± 36.82 309.39 ± 34.68 336.82 ± 37.38 278.72 ± 29.42
Table 3
Protein contents of malignant biological behavior-related molecules in gastric cancer cell lines.
Cell lines Proliferation-related molecules Invasion molecules
CyclinB1 CyclinD1 CyclinE MMP-2 VEGF
SGC7901 63.34 ± 7.97 54.53 ± 6.51 71.47 ± 8.87 68.12 ± 7.24 59.18 ± 5.67
BGC823 177.59 ± 19.54 152.37 ± 17.86 166.45 ± 18.14 170.23 ± 19.24 161.23 ± 18.52
AGS 100.00 ± 14.81 100.00 ± 11.94 100.00 ± 12.52 100.00 ± 13.42 100.00 ± 14.12
MGC803 287.43 ± 29.28 312.59 ± 36.58 298.46 ± 34.13 305.32 ± 35.67 273.31 ± 31.52
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comparison showed: mRNA expression levels and protein
expression levels of TRAP1 in MGC803 were the highest, and
mRNA expression levels and protein expression levels of
TRAP1 in SGC7901 were the lowest.
3.3. Expression of malignant biological behavior-
related molecules in gastric cancer cell lines
Variance of analysis showed that mRNA and protein
expression levels of CyclinB1, CyclinD1, CyclinE, MMP-2 and
VEGF in gastric cancer cell lines SGC7901, BGC823, AGS and
MGC803 had differences; pair wise comparison by LSD-t test
showed that mRNA and protein expression levels of CyclinB1,
CyclinD1, CyclinE, MMP-2 and VEGF in MGC803 were the
highest, and mRNA and protein expression levels of CyclinB1,
CyclinD1, CyclinE, MMP-2 and VEGF in SGC7901 were the
lowest (Tables 2 and 3).
3.4. Correlation between TRAP1 expression level and
expression levels of malignant biological behavior-
related molecules
Pearson correlation analysis showed that mRNA and protein
expression levels of TRAP1 in gastric cancer cell lines were
positively correlated with mRNA and protein expression levels
of CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF (P < 0.05)
(Table 4).Table 4
Correlation between TRAP1 expression level and expression levels of
CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF.
Indexes mRNA expression level Protein expression level
Correlation
coefﬁcient r
Statistics P
value
Correlation
coefﬁcient r
Statistics P
value
CyclinB1 0.781 14.123 <0.05 0.691 15.284 <0.05
CyclinD1 0.669 9.994 <0.05 0.745 12.145 <0.05
CyclinE 0.727 12.478 <0.05 0.772 10.955 <0.05
VEGF 0.718 10.949 <0.05 0.663 8.494 <0.05
MMP-2 0.678 15.502 <0.05 0.714 13.176 <0.054. Discussion
TRAP1 is a member of heat shock proteins (HSP) and also
known as HSP75 [5]. The protein locates in the mitochondria and
can inhibit the survival of reactive oxygen species ROS, thereby
protecting cells against the effect of mitochondrial apoptosis
mechanism and guaranteeing the continuing proliferation state
of cells [6,7]. TRAP1 is widely distributed in multiple organs
and tissues in the body, and mRNA of TRAP1 is detected in
parts including liver, heart, digestive tract, skeletal muscle,
kidney and breast [8–11]. In recent years, the relationship
between TRAP1 and the occurrence and development of
malignant tumors has received attention from more and more
scholars, and TRAP1 positive expression is regarded as an
independent predictor of the survival and recurrent time of
patients with malignant tumors [12,13]. Studies of Condelli [14]
report that TRAP1 can participate in the occurrence and
development of colorectal cancer through BRAF pathway, and
studies of Ou [12] believe that TRAP1 can activate STAT3/
MMP2 pathway and cause the occurrence of esophageal cancer.
Based on above studies and reports, TRAP1 is related to the
occurrence of a variety of digestive tract tumors, therefore it was
speculated that TRAP1 might be involved in the occurrence of
gastric cancer. In order to verify whether TRAP1 was related to
the occurrence of gastric cancer, TRAP1 expression levels in
gastric cancer tissue and adjacent normal tissue were analyzed at
ﬁrst, and results showed that mRNA and protein expression
levels of TRAP1 in gastric cancer tissue were signiﬁcantly
higher than those in adjacent normal tissue, which could pre-
liminarily indicate that TRAP1 was related to the occurrence of
gastric cancer. In order to further verify whether TRAP1 was
related to the clinical progress and pathological process of
gastric cancer, the expression levels of TRAP1 in gastric cancer
tissue with different clinical pathological features were analyzed,
and results showed that mRNA and protein expression levels of
TRAP1 in gastric cancer tissue with muscularis and serosa
inﬁltration, lymph node metastasis, distant organ metastasis and
TNM Ⅲ/Ⅳ stage signiﬁcantly increased, which indicated that
TRAP1 was involved in the development of gastric cancer and
closely related to the local inﬁltration and distant metastasis of
gastric cancer.
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size increase as well as local inﬁltration and distant metastasis of
cancer cells, and above changes are closely related to malignant
biological behaviors such as cancer cell proliferation, migration
and invasion [15,16]. According to the above analysis, TRAP1
participates in the occurrence of gastric cancer and disease
progress, and occurrence and development of gastric cancer
involve the changes of malignant biological behaviors of
cancer cells. Therefore, it was considered that TRAP1 might
be involved in the occurrence and development of gastric
cancer by regulating malignant biological behaviors such as
gastric cancer cell proliferation, migration and invasion. In
order to clarify whether TRAP1 had regulatory effect on
malignant biological behaviors of gastric cancer cells, four
different gastric cancer cell lines were selected as research
subjects, expression of TRAP1 in cells was analyzed, and
results showed that mRNA and protein expression levels of
TRAP1 in MGC803 were the highest, and mRNA and protein
expression levels of TRAP1 in SGC7901 were the lowest. It
indicated that expression levels of TRAP1 in different gastric
cancer cell lines had differences, which might cause changes
of biological behaviors of cancer cells.
Existing basic research suggests that malignant biological
behaviors related to the occurrence and development of gastric
cancer include cancer cell proliferation, migration and invasion.
Completion of these biological behaviors requires the partici-
pation of a variety of molecules. Cyclins are a group of proteins
closely related to cell cycle progress and cell proliferation,
include CyclinB1, CyclinD1 and CyclinE, etc [17,18], and can
form Cyclins–CDKs complex with corresponding cyclin-
dependent kinases (CDKs), thus regulating the start and
running of cell cycle and conducive to cell proliferation [19,20].
VEGF and MMP2 are two molecules closely related to cell
invasion and metastasis. MMP2 can degrade extracellular
matrix and make cancer cells break through the limit of local
basement membrane and inﬁltrate to local parts [21,22]; VEGF
can increase the number of local angiogenesis, which provides
the energy for cellular inﬁltration as well as the path for
cellular transfer through blood [23,24]. Analysis of the
expression of proliferation and invasion-related molecules in
four cell lines showed that mRNA and protein expression levels
of CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF in
MGC803 were the highest, and mRNA and protein expression
levels of CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF in
SGC7901 were the lowest.
According to the analysis of experimental results in above
cell lines, expression level of TRAP1 in MGC803 cell lines was
the highest, and expression level of TRAP1 in SGC7901 cell
lines was the lowest; correspondingly, expression levels of
proliferation and invasion-related molecules in MGC803 cell
lines were the highest, and expression levels of proliferation and
invasion-related molecules in SGC7901 cell lines were the
lowest. Therefore, it was analyzed that the trend of TRAP1
expression levels in different gastric cancer cell lines was
consistent with that of expression levels of proliferation and
invasion-related molecules, and Pearson correlation analysis
showed that mRNA and protein expression levels of TRAP1
were positively correlated with mRNA and protein expression
levels of CyclinB1, CyclinD1, CyclinE, MMP-2 and VEGF,
which could further indicate that the changes of TRAP1
expression levels in gastric cancer cell lines might affect the
expression of CyclinB1, CyclinD1, CyclinE, MMP-2 andVEGF. Above opinions about TRAP1 regulating the expression
of proliferation and invasion-related molecules come from cor-
relation analysis and still need next experiments to overexpress
or knockdown TRAP1 to verify the expression changes of
proliferation and invasion-related molecules.
Based on the above discussion, it is believed that the
expression of TRAP1 signiﬁcantly increases in gastric cancer
tissue; TRAP1 may regulate the malignant biology of cells by
increasing the expression of CyclinB1, CyclinD1, CyclinE,
MMP-2 and VEGF, thereby resulting in the occurrence and
development of gastric cancer.
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